Table 2.
Characteristics of blood pressure assessed by different methods and used antihypertensive drugs.
| Variables | |
|---|---|
| Years of evolution of hypertension | 7.0 ± 5.5 |
| Subjects receiving drug treatment n(%) | 101(39.1) |
| Patients with white coat hypertension n(%) | 32(20.4) |
| Drugs used in treatment | |
| Diuretics n(%) | 44(17.1) |
| ACE inhibitors n(%) | 37(14.3) |
| Angiotensin receptor blockers n (%) | 33(12.8) |
| Calcium channel blockers n (%) | 16(6.2) |
| Office BP (mmHg) | |
| SBP, mm Hg | 139.9 ± 16.8 |
| DBP, mm Hg | 88.3 ± 10.7 |
| PP, mm Hg | 52.2 ± 12.8 |
| HR bpm | 72.1 ± 12.9 |
| ABPM 24 hours (mmHg) | |
| SBP, mm Hg | 126.7 ± 12.8 |
| DBP, mm Hg | 78.7 ± 9.9 |
| PP, mm Hg | 47.9 ± 9.5 |
| HR bpm | 71.9 ± 10.6 |
| SD SBP | 13.8 ± 3.3 |
| SD DBP | 11.3 ± 2.4 |
| N° blood pressure measurement | 60 |
| Awake time ABMP (mmHg) | |
| SBP, mm Hg | 130.6 ± 13.3 |
| DBP, mm Hg | 82.3 ± 10.6 |
| PP, mm Hg | 48.4 ± 9.5 |
| HR bpm | 75.1 ± 11.6 |
| SD SBP | 11.9 ± 3.3 |
| SD DBP | 9.5 ± 2.5 |
| N° blood pressure measurement | 45 |
| Sleep time ABPM (mmHg) | |
| SBP, mm Hg | 115.1 ± 14.5 |
| DBP, mm Hg | 68.3 ± 9.9 |
| PP, mm Hg | 46.9 ± 10.2 |
| HR bpm | 62.6 ± 9.2 |
| SD SBP | 10.3 ± 3.5 |
| SD DBP | 9.1 ± 2.8 |
| N° blood pressure measurement | 15 |
| Sleep/Awake ratio SBP | 0.9 ± 0.1 |
| Sleep/Awake ratio DBP | 0.8 ± 0.1 |
| % Dipping Systolic | 11.7 ± 8.0 |
| HOME BP (mmHg) | |
| SBP, mm Hg | 127.2 ± 14.4 |
| DBP, mm Hg | 81.6 ± 9.8 |
| PP, mm Hg | 45.6 ± 10.1 |
| HR bpm | 68.4 ± 9.1 |
| SD SBP | 9.1 ± 3.4 |
| SD DBP | 6.2 ± 2.3 |
| N° blood pressure measurement | 28 |
Data for qualitative variables are expressed as n (%) and quantitative variables as mean ± standard deviation.
ACE: angiotensin-converting enzyme; SBP: systolic blood pressure; DBP: dyastolic blood pressure; PP: pulse pressure; HR: heart rate; bpm: beats per minute; ABPM: ambulatory blood pressure monitoring; BP: blood pressure.